Part of Speech: n.
Quotation: Q: Will large drugmakers rely even more heavily on buying the rights to discoveries made by others, a practice called inlicensing? A: Inlicensing has been an important source of new medicines for Pfizer, providing about 40 percent of the company’s drug development pipeline. I see us continuing to partner with small companies and academic institutions.
Publishing Location:
Raleigh, North Carolina
Date of Publication:
Sept. 10, 2008
This catchword has yet to be researched.